Ratings Aegon Ltd.

Equities

AGN

BMG0112X1056

End-of-day quote Euronext Amsterdam Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
6.314 ^EUR	+0.57%		+2.90%	+20.31%

17/05	News Highlights : Top Financial Services News of the Day - Friday at 12 AM ET	DJ
16/05	AEGON : New SBB and CFO, results broadly in line

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company appears to be poorly valued given its net asset value.
The company is one of the best yield companies with high dividend expectations.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
AEGON LTD.	+20.31%	12.03B	A
AXA	+14.24%	80.59B	B-
METLIFE, INC.	+12.23%	52.78B	B+
AFLAC INCORPORATED	+7.12%	50.21B	B
MANULIFE FINANCIAL CORPORATION	+24.11%	47.96B	B+
PRUDENTIAL FINANCIAL, INC.	+16.97%	43.56B	B+
GENERALI	+30.23%	41.99B	B
SUN LIFE FINANCIAL INC.	+2.40%	30.06B	B
GREAT-WEST LIFECO INC.	-2.49%	29.32B	B-
PRUDENTIAL PLC	-7.66%	28.52B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes